AYRO, Inc. announced the launch of the Electric Vaccine Vehicle (EVV), which is designed to mobilize a flexible, safe and efficient means of delivering vaccines and testing to millions of people in 2021 and beyond, according to the company.
With the announcement, AYRO, which is a designer and manufacturer of light-duty, short-haul, and last-mile delivery electric vehicles (EVs), said Element Fleet Management will offer sales, financing solutions and vehicle management services throughout the vehicle lifecycle to EVV fleet operators.
Meanwhile, Club Car will provide sales and service support for the vehicles to Element and its clients. Each company will leverage its national footprint and expertise to facilitate the deployment of EVVs and meet urgent demand.
“Element is pleased to bring our broad network, scalable operating platform and industry-leading strategic consulting services to support our existing and prospective clients interested in the EVV,” said David Madrigal, executive vice president and CCO for Element. “We look forward to being part of the Club Car, AYRO and Gallery teams helping to bring an innovative solution to vaccine distribution.”
The EVV is a self-contained, all-electric transportation solution that has been optimized to store, transport, and deliver testing and vaccines to a large population, according to the company.
It is designed to make safe and rapid COVID-19 testing and vaccine distribution possible by reaching patients in need and managing demand at aggregation centers. It can traverse tight areas and help reduce wait times at central distribution locations by meeting patients at their place in line, the company said. When configured as a street-legal vehicle it can serve populations unable to get to vaccination sites because they don’t have access to transportation —including millions of high-risk older adults and low-income households.
The EVV is outfitted with an ultra-low temperature freezer and refrigeration units with Bluetooth-enabled data loggers and temperature monitoring devices to virtually track and log live inside readings and pharmaceutical conditions, which follows CDC guidelines to safely store and distribute vaccines.
It also has a 50-mile driving range plus approximately 6-8 hours of equipment operation on a single charge (depending on EVV configuration and driving conditions), or can provide all-day operations if plugged in, the company said. Each vehicle can be charged and/or operated using a standard 110V/20amp outlet, so no EV charging infrastructure is required.
Additionally, each vehicle as a vaccine station takes up less than 100 square feet, allowing for easy group deployments. Vaccine administration can also happen while the patient is still inside his or her own vehicle or directly outside of the EVV for a rapid, drive-through experience.
Select EVV configurations can be registered and licensed to operate at 25 MPH on city streets with posted speeds up to 35 MPH, the company said. The low-speed EV can also maneuver through car-free zones bringing essential services directly to patients that need them.